Immunotherapy for intracranial hemorrhage

摘要

A binding protein for the treatment of intracranial hemorrhage, wherein the binding protein is capable of binding to the N-terminal domain of the NMDA receptor subunit NR1 (ATD NR1) thereby preventing the t-PA induced proteolysis of the NR1 subunit.